FDA approves Carvykti as second CAR T-cell therapy for advanced multiple myeloma

Press/Media

Period	1 Mar 2022

Media coverage

Title	FDA approves Carvykti as second CAR T-cell therapy for advanced multiple myeloma
Media name/outlet	Healio
Country/Territory	United States
Date	1/03/22
URL	https://www.healio.com/news/hematology-oncology/20220301/fda-approves-carvykti-as-second-car-tcell-therapy-for-advanced-multiple-myeloma
Persons	Sundar Jagannath